National Coverage Analysis (NCA)

Autologous Blood-Derived Products for Chronic Non-Healing Wounds

CAG-00190R4

Expand All | Collapse All

Documents

Contacts

Lead Analysts
David Dolan
david.dolan@cms.hhs.gov
410-786-3365
Lead Medical Officers
James Rollins, MD, PhD

History of Considerations

History Title ID
Original Consideration Autologous Blood-Derived Products for Chronic Non-Healing Wounds CAG-00190N View
First reconsideration Non-Autologous Blood Derived Products for Chronic Non-Healing Wounds CAG-00190R View
Second reconsideration Autologous Blood Derived Products for Chronic Non-Healing Wounds CAG-00190R2 View
Third reconsideration Autologous Blood-Derived Products for Chronic Non-Healing Wounds CAG-00190R3 View
Fourth reconsideration Autologous Blood-Derived Products for Chronic Non-Healing Wounds CAG-00190R4 You are here